Newsfeeds - Spark Newswire

2 minute read

Gretel, Illumina Partner To Develop Synthetic Data For Genomic Research; Terms Not Disclosed

Today, 4:10 PM

Today, Gretel.ai announced a collaboration with Illumina, Inc. (NASDAQ:ILMN), the global leader in DNA sequencing and array-based technologies, to create privacy-protected, synthetic genomic data that can be

ILMN

2 minute read

News

Illumina Supports Norway’s Pioneering Precision Medicine Study to Assess the Efficacy of Blood-based Comprehensive Genomic Profiling in Cancer Therapy Selection Testing

By Charles Gross

Today, 4:10 PM

Illumina, Inc. (NASDAQ: ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing.

ILMN

1 minute read

Why Jim Cramer Likes Illumina, SoFi And More

By Craig Jones

Today, 4:10 PM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ: SOFI) CEO Anthony Noto is "doing a very good job." The company’s stock tumbled after the company announced a common stock offering by selling shareholders.

AOBC

2 minute read

News

GRAIL Announces Partnership With Alignment Health Plan As First Medicare Advantage Plan To Offer Galleri Multi-Cancer Early Detection Blood Test

By Benzinga Newsdesk

Today, 4:10 PM

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, announced today a partnership with Alignment Health Plan, a national Medicare Advantage health plan from Alignment Healthcare

ALHC

5 minute read

Following Rough Year, Is Burning Rock Set To Turn The Corner?

By The Bamboo Works

Today, 4:10 PM

Key Takeaways:

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 4:10 PM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 4:10 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

1 minute read

EC Adopts Interim Measure, Tells Grail To Work On Alternatives To Illumina Deal

By Vandana Singh

Today, 4:10 PM

The European Commission (EC) told Grail to “actively work” on alternatives to its acquisition by Illumina Inc (NASDAQ:ILMN)…

ILMN

1 minute read

Ominous Death Cross Forms On Illumina’s Chart

By Benzinga Insights

Today, 4:10 PM

If history is any guide, there may be trouble ahead for shares of Illumina (NASDAQ:ILMN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

ILMN

1 minute read

‘Halftime Report’ Final Trades From Oct. 25: Illumina, JPMorgan, And More

By Craig Jones

Today, 4:10 PM

On CNBC’s "Halftime Report" final trades, Amy Raskin of Chevy Chase Trust said that the acquisition noise around Illumina, Inc.

AMD